- Home
- Recruiting Trials
Recruiting Trials
Research Area
Study Name
Basic Eligibility
Doctors Referral
Participant Enquiry
Research Area:
Study Name:
SHIVERS
Basic Eligibility:
Viral respiratory disease Acute presentation to Middlemore Emergency Department or Intensive care unit
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible patients with acute presentation at Middlemore Hospital.Research Area:
Study Name:
Start
Basic Eligibility:
Aged between 5 - 14 years Newly diagnosed with Acute rheumatic fever
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible patients currently an inpatient at Middlemore Hospital.Cardiology
Research Area:
Cardiology
Stenosis
Study Name:
DynamX Bioadaptor
Basic Eligibility:
Aged 20 or older, myocardial ischemia, able to undergo PTCA, stenting and CABG
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible patients at Middlemore Hospital.Research Area:
Cardiology
Acute Coronary Syndrome
Study Name:
AEGIS-II (CSL112_3001)
Basic Eligibility:
Type 1 Myocardial infarctionHave at least two coronary artery territories of disease > 50%
Be on treatment for Diabetes
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible patients currently an inpatient at Middlemore Hospital.Diabetes
Research Area:
Diabetes
Diabetic Kidney Disease
Study Name:
Type 2 Diabetes / Chronic Kidney Disease
Basic Eligibility:
Are you aged ≥18 ≤79?Have been receiving stable treatment for your diabetes and diabetic kidney disease for the past 3 months?
Are you able to participate in a study for up to 26 weeks?
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyResearch Area:
Diabetes
Type 2 Diabetes
Study Name:
DeLIVER
Basic Eligibility:
Are you aged between 22 and 70?Have you been diagnosed with Type 2 Diabetes? (HbA1c of 53-86mmol/mol)
Are you on a consistent anti-diabetic drug regimen for at least 90 days?
Do you have a waist circumference ≥102 cm (male) and ≥88 cm (female)?
Have you been diagnosed with hypertension:SBP ≥135 mmHg OR on antihypertensive medications?
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyResearch Area:
Diabetes
Type 2 Diabetes/Obesity
Study Name:
Adolescent Bariatric Study
Basic Eligibility:
Aged between 15 years 9 months and 18Obesity with a BMI >35
Diagnosed with either pre-diabetes or type 2 diabetes
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyGastroenterology/Hepatology
Research Area:
Gastroenterology/Hepatology
Nonalcoholic Steatohepatitis
Study Name:
MK-3655-001-00 (NASH)
Basic Eligibility:
Male or postmenopausal female, aged 18-80 years old, diagnosed Nonalcoholic Steatohepatitis, no other chronic liver disease
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyResearch Area:
Gastroenterology/Hepatology
Chronic Hepatitis B
Study Name:
BRII-179-835-001, DCR-HBVS-101, GS-US-493-5342, Penguin, Piranga [WV41073 (CHB)], VIR (VIR-2218)
Basic Eligibility:
Aged 18 to 65Chronic Hepatitis B infection
On stable NUC treatment (e.g Entecavir orTenofovir)
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyHaematology
Research Area:
Haematology
Follicular Lymphoma
Study Name:
FL212 (BGB-3111-212)
Basic Eligibility:
Age over 18 yearsDiagnosed Follicular Lymphoma
Doctors Referral:
Refer a Patient
Participant Enquiry:
Ask your doctor if this is right for you.Research Area:
Haematology
Myelodysplastic Syndrome (MDS)
Study Name:
KER050 (Anemia in MSD)
Basic Eligibility:
Age ≥ 18Diagnosed with Myelodysplastic Syndrome (MDS)
Anemia
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyResearch Area:
Haematology
Myelofibrosis
Study Name:
MOMENTUM (SRA-MMB-301)
Basic Eligibility:
Age over 18Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post Essential Thrombocythemia Myelofibrosis
Previously treaded with Ruxolitinib
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyResearch Area:
Haematology
Lymphoma - Non-Hodgkins
Study Name:
B-MIND
Basic Eligibility:
Aged 18 years or olderConfirmed diagnosis of DLBCL
Doctors Referral:
Refer a Patient
Participant Enquiry:
Ask your doctor if this is right for you.Research Area:
Haematology
Essential Thrombocythemia
Study Name:
IMG-7289-CTP-201
Basic Eligibility:
Age ≥ 18Diagnosis of Essential Thrombocythemia
Failure of standard therapy, e.g. Hydroxyurea
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyNeonatal
Research Area:
Neonatal
Neonatal care
Study Name:
PAEAN
Basic Eligibility:
Infants born at or more than 35 weeks Indication of perinatal depression
Moderate to severe encephalopathy
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible premature infants at delivery.Plastics and Burns
Research Area:
Plastics and Burns
Wound healing
Study Name:
NPWT
Basic Eligibility:
≥ 18 years of age, undergoing a surgical procedure resulting in a closed approximately linear incision
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible patients at Middlemore Hospital.RSV
Research Area:
RSV
Respiratory syncytial virus
Study Name:
Melody
Basic Eligibility:
Baby born after October 2020, at 35 weeks gestation or above.
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyResearch Area:
RSV
Respiratory syncytial virus
Study Name:
RSV OA
Basic Eligibility:
60 years and older, healthy or medically stable, no flu vaccine in the last 6 months.
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyResearch Area:
RSV
Respiratory syncytial virus
Study Name:
RSV study
Basic Eligibility:
Healthy woman aged between 18 and 49 years of age?Pregnant with no known increased risk for complications?
Singleton pregnancy?
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyRenal
Research Area:
Renal
Hypertension
Study Name:
Polypill
Basic Eligibility:
Aged 18 years or older, hypertensive, no more than 3 current blood-pressure lowering medications.
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyResearch Area:
Renal
IgA Neuropathy
Study Name:
The Align Study
Basic Eligibility:
Aged 18 or older, diagnosis of IgAN, on a stable dose of an ACE inhibitor or ARB / unable to tolerate this therapy.
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyRespiratory
Research Area:
Respiratory
Bronchiectasis
Study Name:
ASPEN
Basic Eligibility:
Aged 18-85, diagnosed non-cystic fibrosis bronchiectasis, two or more exacerbations in the past 12 months.
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyResearch Area:
Respiratory
Chronic obstructive pulmonary disease
Study Name:
PACE
Basic Eligibility:
Aged between 40 and 85 yearsDiagnosed with COPD
A history of cardiovascular disease, including heart failure, ischaemic heart disease, tachyarrhythmias, and hypertension
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyResearch Area:
Respiratory
Bronchiectasis
Study Name:
Resveratrol
Basic Eligibility:
Aged over 18 yearsConfirmed diagnosis of bronchiectasis within 5 years
Pulmonary exacerbation requiring antibiotics in the past 12 months
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyRheumatology
Research Area:
Rheumatology
Ankylosing Spondylitis/Axial Spondyloarthritis
Study Name:
Ankylosing Spondylitis/Axial Spondyloarthritis
Basic Eligibility:
Aged 18 years or olderDiagnosis of Ankylosing Spondylitis or Axial Spondyloarthritis
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyResearch Area:
Rheumatology
Giant Cell Arthritis
Study Name:
Select - GCA (M16-852)
Basic Eligibility:
Age 50 or overDiagnosed Giant Cell Arthritis
Headache, jaw pain, vision loss
Shoulder and/or hip pain
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifySpinal Unit
Research Area:
Spinal Unit
Wound healing
Study Name:
FPH Spinal
Basic Eligibility:
Aged 22 and older, undergoing 1 or 2 level spinal decompression
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible patients at Middlemore Hospital.